Featured Research

from universities, journals, and other organizations

Surviving AIDS Appears To Require Permanent Triple-Drug Therapy

Date:
November 17, 1997
Source:
Johns Hopkins Medical Institutions
Summary:
Researchers from Johns Hopkins, the Aaron Diamond AIDS Research Center (New York, N.Y.) and the University of California, San Diego, have shown that drug "cocktail" therapy for AIDS does not completely clear the body of HIV. Rather, small amounts of the virus remain "hidden" in immune system cells, unable to cause disease or develop resistance to anti-AIDS drugs.

Researchers from Johns Hopkins, the Aaron Diamond AIDS Research Center (New York, N.Y.) and the University of California, San Diego, have shown that drug "cocktail" therapy for AIDS does not completely clear the body of HIV. Rather, small amounts of the virus remain "hidden" in immune system cells, unable to cause disease or develop resistance to anti-AIDS drugs.

Related Articles


The findings give hope for long-term survival with HIV infection. But the results also suggest these individuals must continue multiple-drug therapy to prevent reactivation of the infection and active disease. The "cocktail" comprises the relatively new protease inhibitors, plus such long-used drugs as AZT and ddI.

"The bad news is we can't yet get rid of the virus entirely," says Robert F. Siliciano, M.D., associate professor of medicine. "The number of immune system cells that remain infected with HIV declines only very slowly. But the good news is that as long as people infected with HIV keep taking the triple-drug cocktail, they have an excellent chance of surviving the infection for a long time, without developing symptoms of the disease." Siliciano is senior author of an article reporting these results in the Nov. 14 issue of Science.

The study was funded by the National Institutes of Health (Center for AIDS Research) and by the Research Center for AIDS and HIV Infection of the San Diego Veterans Affairs Medical Center.

The new results follow reports by Aaron Diamond researcher David Ho, M.D. that drug cocktail therapy reduced HIV to such low levels it was no longer detectable. Ho suggested that treatment might stop active replication of the virus completely. The present study was undertaken to find and measure HIV "reservoirs" if they existed.

"Ho's idea of measuring the decline in the level of HIV in various reservoirs of the virus was a revolutionary way of looking at the disease," says Siliciano. "Our study identified a specific reservoir that may persist for a long time."

The Hopkins-led researchers studied 22 patients treated with triple-drug therapy for up to 30 months. The patients, who were treated at the Johns Hopkins AIDS Service, received close supervision to ensure they remained on their demanding treatment schedule. This prevented patients from suffering rebounds in their HIV levels and provided the team with a group of individuals with no detectable levels of HIV measurable by standard laboratory methods.

CD4+ lymphocytes are immune system cells targeted by HIV. Most CD4+ lymphocytes infected with HIV produce many copies of the virus before dying. But some of these infected cells survive, become inactive, and enter a resting phase. During the resting phase, these infected cells do not produce new copies of HIV, but remain a reservoir of the virus that triple-drug therapy cannot eliminate, the researchers say.

"We studied patients whose viral loads had been undetectable for prolonged periods of time," says Joel Gallant, M.D., director of the AIDS outpatient clinic. "That kind of success in keeping levels so low was achieved by the combined efforts of our AIDS Service staff and highly motivated patients. That was important in our ability to study HIV in their resting CD4+ cells."

Several Hopkins scientists, led by Joseph B. Margolick, M.D., Ph.D., used a sophisticated cell-sorting technique called flow cytometry to produce very pure populations of resting CD4+ cells from the partially purified cells provided by Siliciano. "We have a special facility for sorting out cells from HIV-infected people, while minimizing hazard to laboratory workers," Margolick says.

"Using the highly purified cells, we found that even after triple-drug therapy reduced HIV to undetectable levels, AIDS virus genetic material remained "hidden" inside "resting" CD4+ lymphocytes," says Diana Finzi, a graduate student working with Siliciano, and lead author of the study. "The team also showed that when the resting cells were stimulated to reproduce, the AIDS virus also replicated."

The multi-institutional study also found that "cocktail" therapy increased the numbers of healthy, uninfected CD4+ cells in all patients--strong evidence that the treatment was successful despite the potentially deadly reservoir of HIV in resting CD4+ cells.

"Fortunately, however, HIV in these resting cells doesn't appear to mutate into drug-resistant forms during triple-drug therapy," Siliciano says. "And because the virus mutates only when it's replicating, this lack of drug resistance suggests the virus is not replicating. So this is a strong argument for not taking these patients off triple-drug therapy."

Other authors of the paper include Martin Markowitz and David Ho (Aaron Diamond AIDS Research Center, New York, N.Y.); Douglas D. Richman (University of California, San Diego); and Monika Hermankova, Theodore Pierson, Lucy M. Carruth, Christopher Buck, Richard Chaisson, Thomas Quinn, Karen Chadwick, and Ronald Brookmeyer (Johns Hopkins).


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Surviving AIDS Appears To Require Permanent Triple-Drug Therapy." ScienceDaily. ScienceDaily, 17 November 1997. <www.sciencedaily.com/releases/1997/11/971117123537.htm>.
Johns Hopkins Medical Institutions. (1997, November 17). Surviving AIDS Appears To Require Permanent Triple-Drug Therapy. ScienceDaily. Retrieved January 29, 2015 from www.sciencedaily.com/releases/1997/11/971117123537.htm
Johns Hopkins Medical Institutions. "Surviving AIDS Appears To Require Permanent Triple-Drug Therapy." ScienceDaily. www.sciencedaily.com/releases/1997/11/971117123537.htm (accessed January 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, January 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Malnutrition on the Rise as Violence Flares in C. Africa

Malnutrition on the Rise as Violence Flares in C. Africa

AFP (Jan. 28, 2015) Violence can flare up at any moment in Bambari with only a bridge separating Muslims and Christians. Malnutrition is on the rise and lack of water means simple cooking fires threaten to destroy makeshift camps where people are living. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com
Poultry Culled in Taiwan to Thwart Bird Flu

Poultry Culled in Taiwan to Thwart Bird Flu

Reuters - News Video Online (Jan. 28, 2015) Taiwan culls over a million poultry in efforts to halt various strains of avian flu. Julie Noce reports. Video provided by Reuters
Powered by NewsLook.com
Media Criticizing Parents For Not Vaccinating Children

Media Criticizing Parents For Not Vaccinating Children

Newsy (Jan. 28, 2015) As the Disneyland measles outbreak continues to spread, the media says parents who choose not to vaccinate their children are part of the cause. Video provided by Newsy
Powered by NewsLook.com
Shark Bite Victim Making Amazing Recovery

Shark Bite Victim Making Amazing Recovery

AP (Jan. 27, 2015) A Texas woman who lost more than five pounds of flesh to a shark in the Bahamas earlier this month could be released from a Florida hospital soon. Experts believe she was bitten by a bull shark while snorkeling. (Jan. 27) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins